3 results
Approved WMOPending
To establish the preferred treatment of AIN to prevent the development of severe anal neoplasia (persistent AIN III or anal carcinoma) in HIV+ MSM and HIV+ woman.
Approved WMOPending
Primary Objectives:* To compare overall survival (OS) of patients who receive NKTR-102given once every 21 days (q21d) to patients who receive Treatment ofPhysician*s Choice (TPC) selected from the following list of seven singleagentintravenous…
Approved WMOPending
The aim of this study is to measure microcirculation density and flow parameters and oxygenation parameters in oral mucosa before and after 30 min of oral cooling with two different cooling methods, in an effort to identify whether oral cooling has…